![PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management](https://i1.rgstatic.net/publication/320766248_Corrigendum_Third_European_Evidence-based_Consensus_on_Diagnosis_and_Management_of_Ulcerative_Colitis_Part_2_Current_Management/links/5a019efda6fdcc232e2c7b4d/largepreview.png)
PDF) Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
![PDF) Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis PDF) Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis](https://i1.rgstatic.net/publication/340004460_Lymphocyte_Activation_Gene_LAG-3_Is_Associated_With_Mucosal_Inflammation_and_Disease_Activity_in_Ulcerative_Colitis/links/5e78ba49299bf1892c0235fe/largepreview.png)
PDF) Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
![Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020 | Journal of Investigative Medicine Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020 | Journal of Investigative Medicine](https://jim.bmj.com/sites/default/files/highwire/jim/70/8.cover-source.jpg)
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020 | Journal of Investigative Medicine
![Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options? Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options?](https://assets.cureus.com/uploads/figure/file/286749/b8b7ea60463311ecb976955336d4f7bc-Figure-1.png)
Cureus | Prediction of Mucosal Health by NLR, CRP x NLR and MPV in Ulcerative Colitis: Can Their Availability Change According to Treatment Options?
![Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c080de5c-6f74-48b3-9608-bd6feb7e6dce/apt16923-toc-0001-m.jpg?trick=1656871978222)
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study - Pugliese - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders](https://i1.rgstatic.net/publication/313331403_Third_European_Evidence-based_Consensus_on_Diagnosis_and_Management_of_Ulcerative_Colitis_Part_1_Definitions_Diagnosis_Extra-intestinal_Manifestations_Pregnancy_Cancer_Surveillance_Surgery_and_Ileo-an/links/5b0c28714585157f871ca578/largepreview.png)
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
![Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev - Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -](https://almclinmed.ru/files/journals/1/articles/1619/supp/1619-7803-1-SP.jpg)
Real world practice of medical treatment for moderate and severe inflammatory bowel diseases in Russian Federation, Republic of Belarus and Republic of Kazakhstan: intermediate results of the INTENT study - Knyazev -
![Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?](https://www.frontiersin.org/files/Articles/754413/fimmu-12-754413-HTML-r1/image_m/fimmu-12-754413-g001.jpg)
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
![Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records | Upsala Journal of Medical Sciences Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records | Upsala Journal of Medical Sciences](https://ujms.net/public/site/images/ecsemiczky/doaj-seal.png)
Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records | Upsala Journal of Medical Sciences
![Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology](https://bmjopengastro.bmj.com/content/bmjgast/7/1/e000456/F1.large.jpg)
Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis | BMJ Open Gastroenterology
![Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence](https://www.frontiersin.org/files/MyHome%20Article%20Library/708310/708310_Thumb_400.jpg)
Frontiers | Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence
![Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology](https://fg.bmj.com/sites/default/files/highwire/flgastro/12/6.cover-source.jpg)
Constipation in ulcerative colitis: pathophysiology and practical management | Frontline Gastroenterology
![PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management](https://i1.rgstatic.net/publication/317005537_Third_European_Evidence-based_Consensus_on_Diagnosis_and_Management_of_Ulcerative_Colitis_Part_2_Current_Management/links/5b9d53eb45851574f7ce3791/largepreview.png)
PDF) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
![Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect Infliximab formulation strategy for a stable ileo-colonic targeted oral dosage form intended for the topical treatment of inflammatory bowel disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S177322472100232X-ga1.jpg)